ArticlePloS one2026
Protocol for the development of a procedure guide on Laparoscopic Cholecystectomy: Beyond bile duct injury prevention.
Article in PloS one, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
- Erratum issued
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundLaparoscopic cholecystectomy is one of the most frequently performed operations worldwide and the standard treatment for benign gallbladder disease. Although several "safe cholecystectomy" initiatives aim to prevent bile duct injury, current guidelines do not comprehensively address the intraoperative technical conduct of the procedure. Key elements-including exposure, dissection techniques, technical sequencing, and intraoperative decision-making-remain inconsistently defined. This protocol describes the development of an evidence-based, globally applicable clinical procedure guideline intended to standardize technical performance, enhance patient safety, and support surgical training and quality improvement.
methodsThe guideline will be developed following AGREE II standards to ensure methodological rigor, transparency, and stakeholder involvement. The Guideline Development Group comprises coordinators, a steering committee, and multidisciplinary experts from surgical societies and academic institutions. Clinical questions will be generated using the PICO framework and refined through a Delphi consensus process following the ACCORD guideline. For each question, systematic literature searches will be conducted in accordance with PRISMA standards. When feasible, evidence will be synthesized using pairwise or network meta-analysis (PRISMA-NMA, PRISMA-Search); when quantitative synthesis is not possible, findings will be summarized narratively using SWiM guidance. Study selection, data extraction, and risk-of-bias assessment will be performed independently using validated tools (ROB 2.0, ROBINS-I, AMSTAR-2), with search management in Rayyan®. Recommendations will be developed using the GRADE approach, with evidence profiles created in GRADEpro GDT. A second Delphi process will be conducted to reach consensus on each recommendation, applying predefined thresholds for participation and agreement. DISCUSSION: This guideline seeks to fill a critical gap in the technical standardization of laparoscopic cholecystectomy by providing a comprehensive, evidence-based framework that extends beyond bile duct injury prevention. Existing guidelines lack methodological rigor and fail to address key intraoperative elements such as exposure, dissection strategies, and decision-making. Through systematic evidence synthesis and consensus processes, this project aims to harmonize global surgical practice and establish a benchmark for training, safety, and quality improvement. REGISTRATION: This protocol was prospectively registered in the Open Science Framework on December 18, 2025 (https://doi.org/10.17605/OSF.IO/78QSE).
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.